Dr. Thomas Kerscher, Ph.D, Studied Chemistry at the Ludwigs-Maximilian-University in Munich, and started his career as a Sales Representative for children's vaccines in Germany.
Consequently, he held positions with increasing responsibilities, such as Business Unit Leadership in Germany for Novartis, Global Franchise Head for Takeda, and General Manager positions for Aspen Pharmaceuticals. During his time at Shire, he fully focused on the well-being of patients as Global Head Patient Services for the Shire rare disease portfolio. In 2018, he founded the Business-Impact Gmbh (www.business-impact.ch) where he leverages his entrepreneurial skills to support start-ups in Switzerland and Germany. He is an active member of Business Angels Switzerland and the Health Care Shapers.
||Marketing & Financial Strategy